nach oben

Journal of Neurology

Erschienen in:

03.06.2020 | Review

Direct admission versus secondary transfer for acute ischemic stroke patients treated with thrombectomy: a systematic review and meta-analysis

verfasst von: Weisong Zhao, Pengju Ma, Jinbao Chen, Xuejing Yue

Erschienen in: Journal of Neurology | Ausgabe 10/2021

Einloggen, um Zugang zu erhalten

Abstract

Background and purpose

Randomized controlled trials have demonstrated that mechanical thrombectomy (MT) could provide more benefit than standard medical care for acute ischemic stroke (AIS) patients due to emergent large vessel occlusion. However, most primary stroke centers (PSCs) are unable to perform MT, and MT can only be performed in comprehensive stroke centers (CSCs) with on-site interventional neuroradiologic services. Therefore, there is an ongoing debate regarding whether patients with suspected AIS should be directly admitted to CSCs or secondarily transferred to CSCs from PSCs. This meta-analysis was aimed to investigate the two transportation paradigms of direct admission and secondary transfer, which one could provide more benefit for AIS patients treated with MT.

Methods

We conducted a systematic review and meta-analysis through searching PubMed, Embase and the Cochrane Library database up to March 2020. Primary outcomes are as follows: symptomatic intracerebral hemorrhage (sICH) within 7 days; favorable functional outcome at 3 months; mortality in hospital; mortality at 3 months; and successful recanalization rate.

Results

Our pooled results showed that patients directly admitted to CSCs had higher chances of achieving a favorable functional outcome at 3 months than those secondarily transferred to CSCs (OR = 1.26; 95% CI, 1.12–1.42; P < 0.001). In addition, no significant difference was found between the two transportation paradigms in the rate of sICH (OR = 0.86; 95% CI, 0.62–1.18; P = 0.35), mortality in hospital (OR = 0.84; 95% CI, 0.51–1.39; P = 0.51), mortality at 3 months (OR = 1.01; 95% CI, 0.85–1.21; P = 0.91), and successful recanalization (OR = 1.03; 95% CI, 0.88–1.20; P = 0.74). However, in the 100% bridging thrombolysis usage rate subgroup, our subgroup analysis indicated that no difference was found in any outcome between the two transportation paradigms.

Conclusion

Patients with AIS directly admitted to CSCs for MT may be a feasible transportation paradigm for AIS patients. However, more large-scale randomized prospective trials are required to further investigate this issue.

Nur mit Berechtigung zugänglich

Berkhemer OA et al (2015) A randomized trial of intraarterial treatment for acute ischemic stroke. New England J Med 372:11–20. https://doi.org/10.1056/NEJMoa1411587CrossRef

Campbell BCV et al (2015) Endovascular therapy for ischemic stroke with perfusion-imaging selection. New England J Med 372:1009–1018. https://doi.org/10.1056/NEJMoa1414792CrossRef

Goyal M et al (2015) Randomized assessment of rapid endovascular treatment of ischemic stroke. New England J Med 372:1019–1030. https://doi.org/10.1056/NEJMoa1414905CrossRef

Saver JL et al (2015) Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. New England J Med 372:2285–2295. https://doi.org/10.1056/NEJMoa1415061CrossRef

Jovin TG et al (2015) Thrombectomy within 8 hours after symptom onset in ischemic stroke. New England J Med 372:2296–2306. https://doi.org/10.1056/NEJMoa1503780CrossRef

Goyal M et al (2016) Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet (London, England) 387:1723–1731. https://doi.org/10.1016/S0140-6736(16)00163-XCrossRef

Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6:e1000097. https://doi.org/10.1371/journal.pmed.1000097CrossRefPubMedPubMedCentral

Adams KM et al (2019) Outcomes after Thrombectomy in Belfast: Mothership and Drip-and-Ship in the Real World. Cerebrovasc Dis 47:231–237. https://doi.org/10.1159/000500849CrossRefPubMed

Asaithambi G et al (2018) Real-world treatment of large vessel occlusions: combined outcomes of directly presenting and transferred-in patients to a stroke center. Neurol Res 40:637–643. https://doi.org/10.1080/01616412.2018.1460700CrossRefPubMed

10.

Barlinn J et al (2017) Acute endovascular treatment delivery to ischemic stroke patients transferred within a telestroke network: a retrospective observational study. Int J Stroke 12:502–509. https://doi.org/10.1177/1747493016681018CrossRefPubMed

11.

Bücke P et al (2018) Endovascular Thrombectomy in Acute Ischemic Stroke: Outcome in Referred Versus Directly Admitted Patients. Clin Neuroradiol 28:235–244. https://doi.org/10.1007/s00062-017-0558-zCrossRefPubMed

12.

Feil K et al (2020) Drip and ship for mechanical thrombectomy within the Neurovascular Network of Southwest Bavaria. Neurology 94:e453–e463. https://doi.org/10.1212/WNL.0000000000008753CrossRefPubMed

13.

Froehler MT et al (2017) Interhospital Transfer Before Thrombectomy Is Associated With Delayed Treatment and Worse Outcome in the STRATIS Registry (Systematic Evaluation of Patients Treated With Neurothrombectomy Devices for Acute Ischemic Stroke). Circulation 136:2311–2321. https://doi.org/10.1161/circulationaha.117.028920CrossRefPubMedPubMedCentral

14.

Gerschenfeld G et al (2017) Two Paradigms for Endovascular Thrombectomy After Intravenous Thrombolysis for Acute Ischemic Stroke. JAMA Neurol 74:549–556. https://doi.org/10.1001/jamaneurol.2016.5823CrossRefPubMedPubMedCentral

15.

Hiyama N et al (2016) Safety and effectiveness of drip, ship, and retrieve paradigm for acute ischemic stroke: A single center experience. Neurol Med Chir 56:731–736. https://doi.org/10.2176/nmc.oa.2016-0102CrossRef

16.

Jayaraman MV et al (2020) Field triage for endovascular stroke therapy: a population-based comparison. J Neurointervent Surg 12:233–239. https://doi.org/10.1136/neurintsurg-2019-015033CrossRef

17.

Drip PMS et al (2016) ship, and on-demand endovascular therapy for acute ischemic stroke. PLoS ONE. https://doi.org/10.1371/journal.pone.0150668CrossRef

18.

Prothmann S et al (2017) Acute Recanalization of Thrombo-Embolic Ischemic Stroke with pREset (ARTESp): the impact of occlusion time on clinical outcome of directly admitted and transferred patients. J Neurointervent Surg 9:817–822. https://doi.org/10.1136/neurintsurg-2016-012556CrossRef

19.

Rinaldo L et al (2017) Hospital transfer associated with increased mortality after endovascular revascularization for acute ischemic stroke. J Neurointervent Surg 9:1166–1172. https://doi.org/10.1136/neurintsurg-2016-012824CrossRef

20.

Sarraj A et al (2019) Outcomes of thrombectomy in transferred patients with ischemic stroke in the late window: A subanalysis from the defuse 3 trial. JAMA Neurol 76:682–689. https://doi.org/10.1001/jamaneurol.2019.0118CrossRefPubMedPubMedCentral

21.

Seker F et al (2019) Direct Admission vs. Secondary Transfer to a Comprehensive Stroke Center for Thrombectomy: Retrospective Analysis of a Regional Stroke Registry with 2797 Patients. Clin Neuroradiol. https://doi.org/10.1007/s00062-019-00842-9CrossRefPubMed

22.

Shigeta K et al (2019) Widening time disparities between two paradigms: tama-registry of acute endovascular thrombectomy. J Stroke Cerebrovascular Dis 28:1267–1273. https://doi.org/10.1016/j.jstrokecerebrovasdis.2019.01.021CrossRef

23.

Van Veenendaal P et al (2018) Endovascular clot retrieval by hub-and-spoke service delivery is feasible compared with direct-to-mothership. Cerebrovasc Dis 46:170–175. https://doi.org/10.1159/000490421CrossRef

24.

Weber R et al (2016) Outcome and periprocedural time management in referred versus directly admitted stroke patients treated with thrombectomy. Therapeut Adv Neurol Dis 9:79–84. https://doi.org/10.1177/1756285615617081CrossRef

25.

Weisenburger-Lile D et al (2019) Direct admission versus secondary transfer for acute stroke patients treated with intravenous thrombolysis and thrombectomy: Insights from the endovascular treatment in ischemic stroke registry. Cerebrovasc Dis 47:112–120. https://doi.org/10.1159/000499112CrossRefPubMed

26.

Saver JL et al (2015) Stent-retriever thrombectomy after intravenous t-PA vs t-PA alone in stroke. New England J Med 372:2285–2295. https://doi.org/10.1056/NEJMoa1415061CrossRef

27.

Mansoor S, Zand R, Al-Wafai A, Wahba MN, Giraldo EA (2013) Safety of a "drip and ship" intravenous thrombolysis protocol for patients with acute ischemic stroke. J Stroke Cerebrovasc Dis 22:969–971. https://doi.org/10.1016/j.jstrokecerebrovasdis.2011.12.010CrossRefPubMed

28.

Qureshi AI et al (2012) Outcome of the 'Drip-and-Ship' Paradigm among Patients with Acute Ischemic Stroke: Results of a Statewide Study. Cerebrovasc Diseases Extra 2:1–8CrossRef

29.

Silverman IE, Beland DK, Chhabra J, McCullough LD (2005) The, "drip-and-ship" approach: starting IV t-PA for acute ischemic stroke at outside hospitals prior to transfer to a regional stroke center. Conn Med 69:613–620PubMed

30.

Tekle WG et al (2012) Drip-and-ship thrombolytic treatment paradigm among acute ischemic stroke patients in the United States. Stroke 43:1971–1974. https://doi.org/10.1161/STROKEAHA.112.657817CrossRefPubMed

31.

Saver JL et al (2016) Time to Treatment With Endovascular Thrombectomy and Outcomes From Ischemic Stroke: A Meta-analysis. JAMA 316:1279–1288. https://doi.org/10.1001/jama.2016.13647CrossRefPubMed

32.

Goyal M et al (2016) Analysis of Workflow and Time to Treatment and the Effects on Outcome in Endovascular Treatment of Acute Ischemic Stroke: Results from the SWIFT PRIME Randomized Controlled Trial. Radiology 279:888–897. https://doi.org/10.1148/radiol.2016160204CrossRefPubMed

33.

Fan L et al (2020) Outcomes of mechanical thrombectomy with pre-intravenous thrombolysis: a systematic review and meta-analysis. J Neurol. https://doi.org/10.1007/s00415-020-09778-4CrossRefPubMed

34.

Mistry EA et al (2017) Mechanical Thrombectomy Outcomes With and Without Intravenous Thrombolysis in Stroke Patients: A Meta-Analysis. Stroke 48:2450–2456. https://doi.org/10.1161/STROKEAHA.117.017320CrossRefPubMed

35.

Broeg-Morvay A et al (2016) Direct Mechanical Intervention Versus Combined Intravenous and Mechanical Intervention in Large Artery Anterior Circulation Stroke: A Matched-Pairs Analysis. Stroke 47:1037–1044. https://doi.org/10.1161/STROKEAHA.115.011134CrossRefPubMed

36.

Whiteley WN et al (2016) Risk of intracerebral haemorrhage with alteplase after acute ischaemic stroke: a secondary analysis of an individual patient data meta-analysis. Lancet Neurol 15:925–933. https://doi.org/10.1016/s1474-4422(16)30076-xCrossRefPubMed

37.

Lees KR et al (2010) Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet 375:1695–1703. https://doi.org/10.1016/s0140-6736(10)60491-6CrossRefPubMed

38.

Jansen IGH, Mulder M, Goldhoorn RB (2018) Endovascular treatment for acute ischaemic stroke in routine clinical practice: prospective, observational cohort study (MR CLEAN Registry). BMJ Clin Res. https://doi.org/10.1136/bmj.k949CrossRef

39.

van Meenen LCC et al (2020) Interhospital transfer vs direct presentation of patients with a large vessel occlusion not eligible for IV thrombolysis. J Neurol. https://doi.org/10.1007/s00415-020-09812-5CrossRefPubMedPubMedCentral

40.

Rodríguez-Pardo J et al (2020) Prehospital selection of thrombectomy candidates beyond large vessel occlusion: M-DIRECT scale. Neurology. https://doi.org/10.1212/WNL.0000000000008998CrossRefPubMed

41.

Turc G (2017) Mothership or drip-and-ship in the era of thrombectomy: can we use prehospital clinical scales as a compass? Eur J Neurol 24:543–544. https://doi.org/10.1111/ene.13261CrossRefPubMed

Titel: Direct admission versus secondary transfer for acute ischemic stroke patients treated with thrombectomy: a systematic review and meta-analysis
verfasst von: Weisong Zhao
Pengju Ma
Jinbao Chen
Xuejing Yue
Publikationsdatum: 03.06.2020
Verlag: Springer Berlin Heidelberg
Erschienen in: Journal of Neurology / Ausgabe 10/2021
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI: https://doi.org/10.1007/s00415-020-09877-2

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Sozialer Aufstieg verringert Demenzgefahr

24.05.2024 Demenz Nachrichten

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Was nützt die Kraniektomie bei schwerer tiefer Hirnblutung?

17.05.2024 Hirnblutung Nachrichten

Eine Studie zum Nutzen der druckentlastenden Kraniektomie nach schwerer tiefer supratentorieller Hirnblutung deutet einen Nutzen der Operation an. Für überlebende Patienten ist das dennoch nur eine bedingt gute Nachricht.

Thrombektomie auch bei großen Infarkten von Vorteil

16.05.2024 Ischämischer Schlaganfall Nachrichten

Auch ein sehr ausgedehnter ischämischer Schlaganfall scheint an sich kein Grund zu sein, von einer mechanischen Thrombektomie abzusehen. Dafür spricht die LASTE-Studie, an der Patienten und Patientinnen mit einem ASPECTS von maximal 5 beteiligt waren.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Background and purpose

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 10/2021

Cerebral venous sinus thrombosis associated with COVID-19: a case series and literature review

Intravenous immunoglobulin response in new-onset refractory status epilepticus (NORSE) COVID-19 adult patients

Long-term outcomes and prognostic factors in generalized myasthenia gravis

Impact of SARS-CoV-2 on reperfusion therapies for acute ischemic stroke in Lombardy, Italy: the STROKOVID network

Negative anti-SARS-CoV-2 S antibody response following Pfizer SARS-CoV-2 vaccination in a patient on ocrelizumab